Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5418]

Retrospective study of optimal treatment for intermediate-risk testes cancer

Dr Constantine Albany - Indiana University, Indianapolis, USA

Retrospective study of optimal treatment for intermediate-risk testes cancer ( Dr Constantine Albany - Indiana University, Indianapolis, USA )

Effects of age on treatment and outcomes in women with stage IB-IIB cervical...

Dr Don Dizon – Brown University, Providence, USA

Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer ( Dr Don Dizon – Brown University, Providence, USA )

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )

MEK inhibitor, trametinib, improves progression free survival in melanoma

Dr Caroline Robert – Institute Gustave Roussy, Paris, France

MEK inhibitor, trametinib, improves progression free survival in melanoma ( Dr Caroline Robert – Institute Gustave Roussy, Paris, France )

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Dr Jean Yves-Blay - University Claude Bernard, Lyon, France

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma ( Dr Jean Yves-Blay - University Claude Bernard, Lyon, France )

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA

Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA

Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )

Novel PET tracers and their future use in assessment of response to treatment

Dr Andrei Iagaru – Stanford University, CA, USA

Novel PET tracers and their future use in assessment of response to treatment ( Dr Andrei Iagaru – Stanford University, CA, USA )

Treating metastatic melanoma with vemurafenib

Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA

Treating metastatic melanoma with vemurafenib ( Dr Paul Chapman – Memorial Sloan-Kettering Cancer Center, New York, USA )

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA

Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )

Role of family history and genetic testing in diagnosis

Dr Marie Wood – University of Vermont, Burlington, USA

Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )

First line treatment against metastatic breast cancer

Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada

First line treatment against metastatic breast cancer ( Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada )

More from ecancer